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Abstract
Background: Zofenopril is an antioxidant agent which has been shown to have beneficial effects
in hypertension and heart failure. The aim of this study was to test the effects of Zofenopril on
nerve regeneration and scarring in a rat model of peripheral nerve crush injury.
Methods: Twenty-one adult Sprague-Dawley rats underwent a surgical procedure involving right
sciatic nerve crush injury. 15 mg/kg Zofenopril was administered orally to seven rats in group Z for
seven days. Seven rats in group S received saline orally for seven days. Seven rats in the control
group C received no drug after crush injury. Fourteenth and 42nd days after injury, functional and
electromyography assessments of nerves were performed. Functional recovery was analyzed using
a walking track assessment, and quantified using the sciatic functional index (SFI). After these
evaluations, all rats were sacrificed and microscopic evaluations were performed.
Results: The Sciatic functional Index (SFI) in group Z on 14th day is different significantly from
group S and group C (p = 0.037). But on 42nd day there was no difference between groups (p =
0.278). The statistical analyses of electromyelographic (EMG) studies showed that the latency in
group Z is significantly different from group S (p = 0.006) and group C (p = 0.045). But on 42nd day
there was no difference between groups like SFI (p = 0.147). The amplitude was evaluated better
in group Z than others (p < 0.05). In microscopic evaluation, we observed the highest number of
nerve regeneration in the group Z and the lowest in the group C. But it was not significant
statistically.
Conclusion: Our results demonstrate that Zofenopril promotes the regeneration of peripheral
nerve injuries in rat models.
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Introduction
Nerve injuries in extremity surgery occur usually by crush
or tension type rather than incision or rupture. Ortho-
pedic surgeons strive these type problems while treating
long bone fracture and some times after surgical opera-
tions. Demyelinization and remyelinization, axonal
degeneration and regeneration, focal, multifocal or dif-
fuse nerve fiber loss and endoneural edema may be
encountered due to crush injury [1-3]. It is also known
that free oxygen radicals increase and cause tissue damage
due to the tissue destruction after the injury [3,4].
There is an extensive degeneration of the distal segment,
known as Wallerian Degeneration after an axonal lesion
[1]. The proximal stump that is connected to the cell body
can regenerate to reinnervate the target organs especially
in the peripheral nervous system. Although this process is
often facilitated by a permissive environment in the
periphery, some factors can impede normal return to
function, such as the distance from injury site, metabolic
disturbances, age and type of lesion [5-8]. Experimentally,
a lot of medications were used in rat crush injury models
such as steroids, nonsteroidal anti-inflammatory drugs
and vitamins [9-11]. Some antioxidants such as Acetyl-L
carnitine (ALCAR), FK506, polyethylene glycol (PEG) are
used experimentally in treatment of nerve crush injuries
[12-14].
Angiotensin-converting enzyme (ACE) inhibitors are
drugs with different structures and activities used to treat
heart failure and hypertension [15]. Zofenopril and capto-
pril are the only ACE inhibitors with sulphydryl groups
(SH) and consequent potential antioxidant activity [16].
This activity may contribute to the notable cardio- and
endothelium protective effects of Zofenopril [17].
In this study, we have evaluated the effect of Zofenopril
on functional recovery following sciatic nerve crush injury
in rats.
Methods
The experimental protocols have been reviewed and
approved by our University Animal Care and Ethic Com-
mittee. All efforts were made to minimize the number of
animals used and their distress. 21 adult Sprague-Dawley
rats weighing 250–275 g underwent unilateral (right) sci-
atic nerve crush. Test animals in group Z received Zofeno-
pril (15 mg/kg/day for 7 days) (n = 7), group S received
normal saline for 7 days following surgery (n = 7), and
group C control animals (n = 7). The animals were kept in
standard room conditions and fed with standard rat diet
and water ad libitum.
All of the operations were performed under the micro-
scope by same surgeon. The right lateral thigh was oper-
ated, after shaving and preparing the skin with 10%
povidone iodine. The sciatic nerve was exposed by open-
ing the fascial plane between the gluteal and femoral mus-
culature via a longitudinal incision. Under kethamine
anesthesia, the sciatic nerve of 21 rats was exposed at mid-
thigh level and either crushed for 30 seconds with a pair
of jewelers forceps (n = 16). The wound was sutured in
layers and the animals were allowed to recover.
At 2nd and 6th weeks, all animals were evaluated for sciatic
functional index (SFI) by walking tract analysis (WTA)
and electromyelography (EMG).
At 6 weeks after the evaluation, in order to confirm the
nerve recovery, all animals were euthanatized by cervical
dislocation. A 10-mm-long sample of the right sciatic
nerve segment centered to the lesion was removed, fixed,
and prepared for light and electron microscopic examina-
tion. From seven random of these rats, a 10-mm-long
sample of the left sciatic nerve segment without any injury
was removed, fixed, and prepared for histopathological
examination and histomorphometry of myelinated nerve
fibers.
Walking tract analysis
Functional recovery was analyzed using a WTA, and quan-
tified using the sciatic functional index (SFI) [18]. Rats
were tested at 14th and 42nd days after injury. Paw-prints
were recorded by painting the hind paws with black ink
and having them walk along an 8 × 80 cm corridor, lined
with white paper. The paw-prints were collected. Paw
length and toe spread were measured. SFI was calculated
according to the following Medinacelli formula [19]:
Where ETS is the experimental toe spread, NTS the normal
toe spread, EPL the experimental paw length, and NPL is
the normal paw length.
Motor nerve conduction velocity (MNCV)
At the 14th and 42nd days after crush injury, the MNCV
studies were performed under general anesthesia, and
were carried out with a Neuromatic 2000 M/C Neuro-
Myograph (Dantec Elektronic Medicinsk Og Videnskabe-
ligt Maleudstyr A/S, Skovlunde, Denmark). The sciatic
nerve was percutaneously stimulated with supramaximal
stimulus intensity through monopolar needle electrodes,
proximal to the injury site at the level of the sciatic notch,
and distal to the lesion at the level of the ankle. Square
wave stimulus pulses of 500 μsec in duration were deliv-
ered at 1 Hz. Recorded signals were amplified with an
alternating current-coupled preamplifier with filters at 1
Hz and 10 KHz. The latency of the evoked muscle action
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potentials were recorded from the intrinsic foot muscles
with surface electrodes. Finally, the distance between the
two sets of stimulating electrodes was measured on the
skin with a ruler to the nearest 1 mm, and the conduction
velocity was calculated. Both experimental (right) and
normal (left) nerves were measured.
Morphological analysis
The crushed sciatic nerves were immersed immediately
just after sacrification in a drop of fixation solution, con-
taining freshly prepared, ice cold 4% paraformaldehyde
for an hour. Then, they were incubated at 0.5% saccharose
solution in PBS buffer overnight. and embedded on cryo-
matrix (Shandon). 10 μm thick transverse frozen sections
were cut using a cryomicrotome (Leica, CM1900). Sec-
tions were kept in a humidified chamber with wet gauze.
10 μL blocks solution, including 0.1% triton-X, was added
to each section. Panaxonal marker NE 14 (anti-nfh anti-
body) is used for immunhistochemical staining as pri-
mary and anti Mouse IgG 488 antibody as secondary.
Macroscopical nerve evaluation has been performed
according to regenerated axon number by immuno-
flourescent technique. The sections were analyzed using
confocal microscope (Zeiss LSM 510 Meta). Crushed,
proximal and distal to crushed area of the sciatic nerve
were sectioned two times and the averages used for evalu-
ation. They were compared for immunoreactivity with
image analysis. Staining intensity of the crushed, proxi-
mal, distal regions were recorded as percentile. Each
group of experimental rats analyzed statistically.
Statistical Analysis
The data were expressed as means ± SD. Distributions of
the data of the groups were assessed with one-sample Kol-
mogorov-Smirnov Z test and were found normal (P >
0.05). One-way analysis of variance (ANOVA) was per-
formed on the data to examine differences among groups.
If a significant group effect was found, a Tukey HSD test
was used to identify the location of differences between
groups. A p value less than 0.05 was statistically signifi-
cant. Independent Student t test was used to compare
EMG values of intact extremity and operated extremity.
Results
Walking-track analysis
The SFI was greatly decreased for both control and exper-
imental groups 14 days post-injury, and began showing
signs of recovery on day 42nd. The SFI values of group Z
and S (p = 0.037) and C (p = 0.034) were significantly
higher degree in the second week (Figure 1). At sixth week
SFI values were close to each other in all groups. There was
not a statistical difference between groups (p = 0.278). SFI
values for 2nd and 6th weeks are given in Table 1 and Table
2.
The EMG studies of the Subjects on the 14th day showed
that right sciatic nerve has a severe injury according to left
(intact) side that is statistically different (paired t test) (T
= -3.31 P = 0.016).
The EMG measurement of rats in the second week for the
latency significant degree between the groups are different
(p = 0.007). The latency in the 2nd week of the group Z was
significantly lower than group S (p = 0.006) and C (p =
0,045) (Figure 2). But this difference disappeared in the
6th week (p = 0,147). EMG results for 2nd and 6th weeks
are given in Table 1 and 2. The amplitude values are exam-
ined, similar to the latency, there was a significant differ-
ence between the groups (p < 0,001) at 2nd week, but not
on the 6th week (p = 0,374) (Figure 3).
Morphological analysis results
In all groups, lesion area, the proximal and distal parts of
the lesion were estimated microscopically. The number of
the fibrils found decreased in the distal to lesion nerve in
all groups (Figure 4). The lowest regenerated fibril
number estimated in group C, and highest in group Z.
Discussion
Severe anatomical and functional disorders can be seen
after peripheral nerve injury. This type of injury frequency
is increasing with technology in industrialized societies.
Nerve injuries in extremity represent usually by crush or
tension type rather than incision or rupture in surgery or
trauma. Spontaneous regeneration through the distal
nerve stump with good functional return can be expected
Table 1: EMG results for 2nd week, *: Group Z is significantly different.
Zofenopril (Group Z) (n = 7) Saline (Group S)
(n = 7)
Control (Group C) (n = 7) P
SFI (mean ± sd, range) -12.84 ± 2.86
[(-16.92) – (-8.62)]
-22.88 ± 5.03*
[(-32.88)-(-17.55)]
-23.02 ± 10.53*
[(-39.51)-(-12.52)]
0.019
Latency (msec, mean ± sd, range) 1.51 ± 0.28
(1.10–1.90)
2.08 ± 0.23*
(1.80–2.50)
1.90 ± 0.36*
(1.40–2.40)
0.007
Amplitude (mV, mean ± sd, range) 8.77 ± 2.08
(5.70–11.50)
5.12 ± 1.39*
(3.60–7.90)
4.94 ± 1.34*
(3.80–7.50)
< 0.001Journal of Brachial Plexus and Peripheral Nerve Injury 2009, 4:6 http://www.jbppni.com/content/4/1/6
Page 4 of 7
(page number not for citation purposes)
after this type of injury [20,21]. This type of nerve injuries
are treated pharmacological agents instead of surgery.
For this purpose, many pharmacological agents are tried
experimentally and successful results were reported [9-
14]. However, these studies did not go beyond the exper-
imental studies. The healing process after nerve injury is
reduced mainly free oxygen radicals rather than inflam-
mation and edema [2]. Therefore, in recent years many
researchers started to stand on the antioxidant mecha-
nism. Antioxidant materials contribute nerve regeneration
via free oxygen radicals scavenging effect [22]. Antioxidant
enzymes such as superoxide dismutase and catalase and
GSH-Px are found in mammalian organisms and protect
cells from toxic effects of free radicals. While free radicals
production, lipid peroxidation develops on cell mem-
brane and this can lead to final cell death. The protective
antioxidant enzyme activity increases in response to free
radical formation. There are many experimental studies
available showing free radicals production and impor-
tance of lipid peroxidation on cell membrane injury in
nervous system injuries. Free radicals induced traumatic
cell damage is basic mechanism of cell death. Neverthe-
less, catalase and GSH-Px traumatic damage such as the
FOR cleaners provide partial improvement. [23]
Studies using the photo-oxidation of riboflavin sensitized
by dianisidine to generate active oxygen species have
clearly defined the remarkable difference in the antioxi-
dant action of SH-containing compared with non-SH-
containing, ACE inhibitors [24]. The SH-containing, ACE
inhibitors zofenopril, captopril, epicaptopril (the stereoi-
somer of captopril, which is devoid of ACE inhibitory
properties) and fentiapril were found to be effective scav-
engers of non-superoxide free radicals, while four non-
SH-containing ACE inhibitors were inactive. The protec-
tive effects from free radical-induced cell damage of SH-
containing ACE inhibitors have also been assessed in cul-
tured endothelial cells exposed to a superoxide anion and
hydroxyl radical generating system [25]. Pre-incubation of
the cells with captopril, epicaptopril or zofenopril pro-
duced a concentration dependent (10 – 200 μM) inhibi-
Table 2: EMG results for 6th week,
Zofenopril (Group Z) (n = 7) Saline (Group S)
(n = 7)
Control (Group C) (n = 7) P
SFI (mean ± sd, range) -7.19 ± 2.38
[(-12.28) – (-5.67)]
-9.50 ± 3.35
[(-14.11)-(-5.53)]
-12.20 ± 8.90
[(-31.74)-(-5.67)]
0.278
Latency (msec, mean ± sd, range) 1.33 ± 0.23
(1.00–1.60)
1.70 ± 0.31
(1.40–2.20)
1.60 ± 0.46
(1.20–2.40)
0.147
Amplitude (mV, mean ± sd, range) 12.61 ± 2.69
(9.10–16.00)
11.03 ± 3.52
(6.30–17.00)
10.31 ± 2.88
(6.90–14.40)
0.374
Sciatic function index (SFI) results for 2nd week, CI. Confi- dence intervale Figure 1
Sciatic function index (SFI) results for 2nd week, CI. 
Confidence intervale.
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EMG results for 2nd week, (latency), CI. Confidence 
intervale.
7 7 7 N =
GROUP
Control Saline Zofenopril
9
5
%
 
C
I
 
L
a
t
e
n
c
y
 
(
m
s
e
c
)
2.6
2.4
2.2
2.0
1.8
1.6
1.4
1.2
1.0Journal of Brachial Plexus and Peripheral Nerve Injury 2009, 4:6 http://www.jbppni.com/content/4/1/6
Page 5 of 7
(page number not for citation purposes)
EMG results for 2nd week, (amplitude), CI. Confidence intervale Figure 3
EMG results for 2nd week, (amplitude), CI. Confidence intervale.
7 7 7 N =
GROUP
Control Saline Zofenopril
9
5
%
 
C
I
 
A
m
p
l
i
t
u
d
e
 
(
m
V
)
12
10
8
6
4
2
NFH immunoreactivity in the sections of proximal, middle (crush site) and distal parts of the sciatic nerves from animals in con- trol (C), saline (S) and zofenopril (Z) groups Figure 4
NFH immunoreactivity in the sections of proximal, middle (crush site) and distal parts of the sciatic nerves 
from animals in control (C), saline (S) and zofenopril (Z) groups. The lowest regenerated fibril number estimated in 
group C, and highest in group Z.Journal of Brachial Plexus and Peripheral Nerve Injury 2009, 4:6 http://www.jbppni.com/content/4/1/6
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tion of malonyldialdehyde formation. Both loss of cell
viability and membrane blebbing were reduced by SH-
containing ACE inhibitors at concentrations as low as 10
μM. In contrast, lisinopril and enalaprilat were ineffective
at concentrations up to 200 μM.
Because of known antioxidant and free oxygen radicals
scavenging effect of Zofenopril; it is used in experimental
studies on ischemia-reperfusion damages in brain, kid-
ney, heart and liver tissue [26,27].
It has higher lipophilic effect than other ACE inhibitors
with the long-term tissue penetration features tissue. Thus
the long duration of effect is provided. In this way, and
vascular tissue ACE myocardium and other drugs inhibi-
tion effects last much longer and has been shown to be
effective [16].
Sunderland second-degree injury or axonotmesis means a
breakdown of the axon and distal Wallerian degeneration
but keeping of the continuity of the endoneural sheath.
Spontaneous regeneration through the distal nerve stump
with good functional return can be expected after this type
of injury [20,21]. As the restored pattern of innervations is
identical to the original, the study of this nerve lesion pro-
vides a good model for establishing the ontogeny of func-
tional nerve recovery.
Electrophysiological, morphological and histologic stud-
ies were used for evaluation of experimental peripheric
nerve regeneration [1-5]. But none of them was enough to
determine the nerve recovery. Medinacelli at al. reported
walking gait analysis for rat sciatic nerve. Later this
method is modified and named as sciatic functional index
[3].
The SFI increased and normal values were achieved at
week 7 after sciatic nerve injury. Several authors reported
nearly same results whose studies have also shown nor-
mal walking patterns only after the first month of post
crush [28,29]. In contrast to these experiments, some
authors reported a full recovery at the third and fourth
weeks [30]. The difference in the rate of motor functional
recovery may relate to the pathophysiologic response of
peripheral nerves to the magnitude of different crushing
loads [31].
In this study, the SFI in Zofenopril group was significantly
higher than other groups in 2nd week. We believe that this
medication accelerates nerve crush injury healing in rats.
Our findings in SFI and EMG studies in 2nd week support
this improvement. In the second week after injury and the
EMG test results done in six weeks on the morphological
analysis results support these findings.
Conclusion
As a result, Zofenopril has been found effective in promot-
ing nerve regeneration in sciatic nerve crush injury rat
model. These molecules can be used also for the human
injured nerve but additional work is needed.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
AMK designed the study and performed experimental
operations. AD and VB performed statistical analyses. HY
and MAG had performed final operations and specimen
collection of this experimental study. MK had performed
linguistic and technical corrections. All authors read and
approved the final manuscript.
Acknowledgements
The authors are grateful to Murat OZDEMIR, Ali CETINKAYA and Temel 
TOMBUL for the excellent artwork and their technical support.
References
1. Zochodne DW, Ho LT: Endoneural microenvironment and
acute nerve crush injury in the rat sciatic nerve.  Brain Res
1990, 535:43-48.
2. Bagdatoglu C, Saray A, Surucu HS, Ozturk H, Tamer L: Effect of tra-
pidil in ischemia/reperfusion injury of peripheral nerves.  Neu-
rosurgery 2002, 51:212-220.
3. Arslan E, Milcan A, Unal S, Demirkan F, Polat A, Bagdatoglu O, Aksoy
A, Polat G: The effects of carnitine on distally burned dorsal
skin flap: an experimental study in rats.  Burns 2003,
29:221-227.
4. Stoll G, Muller HW: Nerve injury, axonal degeneration and
neuronal regeneration: basic insights.  Brain Pathol 1999,
9:313-325.
5. Gordon T, Sulaiman O, Boyd JG: Experimental strategies to pro-
mote functional recovery after peripheral nerve injuries.  J
Peripher Nerv Syst 2003, 8:236-250.
6. Kennedy JM, Zochodne DW: Impaired peripheral nerve regen-
eration in diabetes mellitus.  J Peripher Nerv Syst 2005,
10:144-157.
7. Verdu E, Ceballos D, Vilches JJ, Navarro X: Influence of aging on
peripheral nerve function and regeneration.  J Peripher Nerv Syst
2000, 5:191-208.
8. Lundborg G: Nerve injury and repair – regeneration, recon-
struction and cortical repair.  Philadelphia: Elsevier/Churchill Liv-
ingstone; 2004. 
9. Al-Bishri A, Dahlin L, Sunzel B, Rosenquist J: Systemic betametha-
sone accelerates functional recovery after a crush injury to
rat sciatic nerve.  J Oral Maxillofac Surg 2005, 63:973-977.
10. Subbanna PK, Prasanna CG, Gunale BK, Tyagi MG: Acetyl salicylic
acid augments functional recovery following sciatic nerve
crush in mice.  J Brachial Plex Peripher Nerve Inj 2007, 2:3.
11. Le Prell CG, Hughes LF, Miller JM: Free radical scavengers vita-
mins A, C, and E plus magnesium reduce noise trauma.  Free
Radic Biol Med 2007, 42:1454-1463.
12. Wilson AD, Hart A, Brännström T, Wiberg M, Terenghi G: Delayed
acetyl-L-carnitine administration and its effect on sensory
neuronal rescue after peripheral nerve injury.  J Plast Reconstr
Aesthet Surg 2007, 60:114-118.
13. Lee M, Doolabh VB, Mackinnon SE, Jost S: FK506 promotes func-
tional recovery in crushed rat sciatic nevre.  Muscle Nerve 2000,
23:633-640.
14. Ditor DS, John SM, Roy J, Marx JC, Kittmer C, Weaver LC: Effects
of polyethylene glycol and magnesium sulfate administration
on clinically relevant neurological outcomes after spinal cord
injury in the rat.  J Neurosci Res 2007, 85:1458-1467.
15. Brown NJ, Vaughan DE: Angiotensin-converting enzyme inhibi-
tors.  Circulation 1998, 97:1411.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Journal of Brachial Plexus and Peripheral Nerve Injury 2009, 4:6 http://www.jbppni.com/content/4/1/6
Page 7 of 7
(page number not for citation purposes)
16. Subissi A, Evangelista S, Giachetti A: Preclinical profile of zofeno-
pril: an angiotensin converting enzyme inhibitor with pecu-
liar cardioprotective properties.  Cardiovasc Drug Rev 1999,
17:115-133.
17. Borghi C, Ambrosioni E: Zofenopril: A review of the evidence of
its benefits in hypertension and acute myocardial infarction.
Clin Drug Invest 2000, 20:371-384.
18. Bain JR, Mackinnon SE, Hunter DA: Functional evaluation of com-
plete sciatic, peroneal, and posterior tibial nerve lesions in
the rat, Plast.  Plast Reconstr Surg.  1989, 83(1):129-138.
19. de Medinaceli L, Freed WJ, Wyatt RJ: An index of the functional
condition of rat sciatic nerve based on measurements made
from walking tracks.  Exp Neurol 1982, 77:634-643.
20. Seddon H: Three types of nerve injury.  Brain 1943, 66:237-288.
21. Sunderland S: The anatomy and physiology of nerve injury.
Muscle Nerve 1990, 13:771-784.
22. Kurtoglu Z, Ozturk AH, Bagdatoglu C, Polat G, Aktekin M, Uzmansel
D, Camdeviren H, Bagdatoglu O, Sargon M: Effects of trapidil after
crush injury in peripheral nerve.  Acta Med Okayama 2005,
59:37-44.
23. Ikeda T, Choi BH, Yee S, Murata Y, Quilligan EJ: Oxidative stress,
brain white matter damage and intrauterine asphyxia in
fetal lambs.  Int J Dev Neurosci 1999, 17:1-14.
24. Chopra M, Beswick H, Clapperton M, Dargie HJ, Smith WE, McMur-
ray J: Antioxidant effects of angiotensin-converting enzyme
(ACE) inhibitors: free radical and oxidant scavenging are
sulfhydryl dependent, but lipid peroxidation is inhibited by
both sulfhydryland nonsulfhydryl-containing ACE inhibitors.
J Cardiovasc Pharmacol 1992, 19:330-340.
25. Mak IT, Freedman AM, Dickens BF, Weglicki WB: Protective
effects of sulfhydryl-containing angiotensin converting
enzyme inhibitors against free radical injury in endothelial
cells.  Biochem Pharmacol 1990, 40:2169-2175.
26. Cushman DW, Wang FL, Fung WC, Harvey CM, DeForrest JM: Dif-
ferentiation of angiotensin-converting enzyme (ace) inhibi-
tors by their selective inhibition of ACE in physiologically
important target organs.  Pharm Res 1992, 9:1480-1486.
27. Altunoluk B, Soylemez H, Oguz F, Turkmen E, Fadillioglu E: An Angi-
otensin-converting enzyme inhibitor, zofenopril, prevents
renal ischemia/reperfusion injury in rats.  Ann Clin Lab Sci 2006,
36:326-332.
28. Gudemez E, Ozer K, Cunningham B, Siemionow K, Browne E, Siemi-
onow M: Dehydroepiandrosterone as an enhancer of func-
tional recovery following crush injury to rat sciatic nerve.
Microsurgery 2002, 22:234-241.
29. Olıveıra EF, Mazzer N, Barbıerı CH, Sellı M: Correlation between
functional index and morphometry to evaluate recovery of
the rat sciatic nerve following crush injury: experimental
study.  J Reconstr Microsurg 2001, 17:69-75.
30. Bridge PM, Ball DJ, Mackinnon SE, Nakao Y, Brandt K, Hunter DA,
Hertl C: Nerve crush injuries – a model for axonotmesis.  Exp
Neurol 1994, 127:284-290.
31. Rempel D, Dahlın L, Lundborg G: Pathophysiology of nerve com-
pression syndromes: response of peripheral nerves to load-
ing.  J Bone Joint Surg Am.  1999, 81(11):1600-1610.